APVO

Latest SEC Filings & News for APVO

2 most recent filings and news items mentioning APVO. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/APVO/news?limit=20"

Pull APVO filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherJul 27, 2026Neutral

Company files patent for Nectin-4 x PD-L1 dual-targeting backbone

Aptevo Therapeutics filed a patent application covering a versatile Nectin-4 x PD-L1 backbone intended to support multiple solid tumor therapies and unlock value for partners.

View filing at SEC.gov →

M&AMay 27, 2026Positive

Aptevo and Niowave launch 50/50 radiopharmaceutical collaboration with 7.9% equity stake

Aptevo Therapeutics and Niowave announced a strategic partnership to develop up to three radiopharmaceutical oncology programs, with Niowave making an at-the-market equity investment representing 7.9% ownership and potential to reach 19.99% through warrants. The collaboration com

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.